Administrative and Protocol Management Core

行政和礼宾管理核心

• 批准号: 8660271
• 负责人: Sharon L. Hillier
• 金额: $ 16.83万
• 依托单位: MAGEE-WOMEN'S RES INST AND FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-06-01 至 2017-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8660271
• 关键词: Acquired Immunodeficiency Syndrome; Agreement; Annual Reports; Basic Science; Budgets; Businesses; Charge; Clinical; Clinical Research; Collaborations; Data; Development; Drug Formulations; Ensure; Expenditure; Film; Goals; Grant; HIV; Human Resources; Individual; Institutes; Institution; Institutional Review Boards; Journals; Lead; Local Microbicides; Modification; National Institute of Allergy and Infectious Disease; New York; Participant; Peer Review; Pharmaceutical Preparations; Play; Preparation; Process; Protocols documentation; Publications; Recommendation; Reporting; Research; Research Activity; Research Personnel; Rights; Role; Schedule; Scientist; Tenofovir; U-Series Cooperative Agreements; UC 781; United States National Institutes of Health; Universities; Washington; Work; Writing; data sharing; meetings; member; microbicide; pre-clinical; programs; protocol development; symposium

The Administrative and Protocol Management Core (Core A) of this grant will provide administrative support for the four scientific projects and two scientific cores for the program entitled, "Alternative Formulations of Tenofovir and UC781". Specifically, the Administrative Core will 1) provide administrative oversight of the scientific projects and cores in this program, 2) provide fiscal oversight and coordination for the program across all projects and cores, 3) be the primary point of contact between this research program and the NIAID Program Officer in charge of the Integrated Preclinical/Clinical Program for HIV Topical Microbicides, 4) plan and coordinate monthly conference calls for the Scientific Steering Committee, 5) establish a Scientific Advisory Panel of outside scientists to attend an annual meeting of the Scientific Steering Committee and NIAID program scientists, and 6) assist Core C with coordination of research activities with corporate partners and CONRAD. In addition, this Core will provide protocol management support for the clinical studies in Projects 3 and 4, and ensure smooth interactions between CONRAD, which holds the proprietary rights to UC781 and tenofovir, the University of Pittsburgh IRB, and the Division of AIDS. This Core, which will be led by Drs. Sharon Hillier and Lisa Rohan, will support all four scientific projects and both scientific cores through the promotion of scientific interactions and collaborations with other investigators engaged in microbicide research.

该赠款的行政和礼宾管理核心（核心 A）将提供行政支持 题为“替代制剂”的计划的四个科学项目和两个科学核心 替诺福韦和 UC781”。具体来说，行政核心将 1) 提供行政监督 该计划中的科学项目和核心，2) 为该计划提供财政监督和协调 跨越所有项目和核心，3) 成为本研究计划与 NIAID 项目官员，负责艾滋病毒局部杀菌剂临床前/临床综合项目， 4) 计划和协调科学指导委员会的每月电话会议， 5) 建立一个 由外部科学家组成的科学顾问小组将出席科学指导年度会议 委员会和 NIAID 项目科学家，以及 6) 协助核心 C 协调研究活动 企业合作伙伴和 CONRAD。此外，该核心将为 项目 3 和 4 的临床研究，并确保 CONRAD 之间的顺利互动，该项目拥有 UC781 和替诺福韦的专有权利、匹兹堡大学 IRB 和艾滋病司。这 核心，将由博士领导。 Sharon Hillier 和 Lisa Rohan 将支持所有四个科学项目 通过促进与其他研究人员的科学互动和合作来形成科学核心 从事杀菌剂研究。